Successful generic drug product development: From research to marketing approval

Successful generic drug product development: From research to marketing approval

Bibliographic Details
Main Author:	Suchart Chongprasert
Format:	Article
Language:	English
Published:	Elsevier 2016-02-01
Series:	Asian Journal of Pharmaceutical Sciences
Subjects:	Drug development Generic product Bioequivalent study
Online Access:	http://www.sciencedirect.com/science/article/pii/S1818087615001233

Similar Items

Generic drugs: myths, facts, and limitations
by: Antonio Marzo, et al.
Published: (2012-10-01)

Scientific and regulatory approaches to confirm quality and improve patient perceptions of generic drug products in Japan
by: Hiroko Shibata, et al.
Published: (2016-10-01)

WHAT IS THERAPEUTIC EQUIVALENCE OF GENERIC DRUG AND HOW TO PROVE IT
by: N. P. Kutishenko, et al.
Published: (2016-01-01)

The concept of: Generic drugs and patented drugs Vs brand name drugs and non-proprietary (generic) name drugs.
by: Karan eThakkar, et al.
Published: (2013-09-01)

Evaluation of Bioequivalence of Generic Imatinib Products and Generic Tacrolimus Products Based on Indirect Comparison of the Results of Their Bioequivalence Studies
by: D. V. Goryachev, et al.
Published: (2019-09-01)

TREATMENT OF OSTEOPOROSIS: CLINICAL EXPERIENCE IN USING A GENERIC DRU
by: Nataliya Vladimirovna Toroptsova, et al.
Published: (2011-03-01)

TREATMENT OF OSTEOPOROSIS: CLINICAL EXPERIENCE IN USING A GENERIC DRU
by: Nataliya Vladimirovna Toroptsova, et al.
Published: (2011-03-01)

Correlation of reference and generic fluconazole-based drugs
by: A. S. Dukhanin
Published: (2020-04-01)

Regulatory requirements for the registration of generic medicines and format of drug dossiers: procedures in Sri Lanka in comparison with selected regulatory authorities
by: D. Thambavita, et al.
Published: (2018-06-01)

Brands and Generics: Criteria for Evaluating the Effectiveness
by: V.V. Poltorak, et al.
Published: (2013-09-01)

A COMPARATIVE ANALYSIS OF BIOEQUIVALENCE, CLINICAL EFFICACY AND SAFETY OF GENERIC VERSUS ORIGINAL CYCLOSPORINE AFTER KIDNEY TRANSPLANTATION
by: E. S. Stolyarevich, et al.
Published: (2015-04-01)

PLANNING AND EVALUATION OF BIOEQUIVALENCE STUDIES OF ATAZANAVIR PRODUCTS
by: N. E. Uvarova, et al.
Published: (2018-12-01)

Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984
by: Garth Boehm, et al.
Published: (2013-09-01)

PROBLEM OF GENERIC REPLACEMENT: ADVANTAGES AND DISADVANTAGES
by: S. N. Tolpygina, et al.
Published: (2016-01-01)

Generic therapy: the problem of choice
by: S. N. Tolpygina
Published: (2009-06-01)

Efficacy and safety of generic imatinib after switching from original imatinib in patients treated for chronic myeloid leukemia in the United States
by: Iman Abou Dalle, et al.
Published: (2019-11-01)

Comparison of the physicochemical properties and in vivo bioavailability of generic and innovator artemether-lumefantrin tablets in Kumasi, Ghana
by: Noble Kuntworbe, et al.
Published: (2018-05-01)

THE PROBLEMS ASSOCIATED WITH SWITCHING BRAND-NAME ANTIEPILEPTIC DRUGS TO GENERICS: A FOCUS ON TOPAMAX: A REVIEW OF LITERATURE AND A CASE REPORT
by: K. Yu. Mukhin, et al.
Published: (2016-08-01)

Meeting Regulatory Requirements for Drugs with a Narrow Therapeutic Index: Bioequivalence Studies of Generic Once-Daily Tacrolimus
by: Gantar K, et al.
Published: (2020-09-01)

Knowledge and Perceptions of Final-Year Medical Students in Yemeni Universities about Generic Medicines
by: Gamil Q. Othman, et al.
Published: (2016-02-01)

Generic sustained release tablets of trimetazidine hydrochloride: Preparation and in vitro–in vivo correlation studies
by: Longmei Wang, et al.
Published: (2016-06-01)

QUALITATIVE DRUG: WHAT SHOULD IT LOOK LIKE?
by: V. V. Iakusevich
Published: (2016-01-01)

Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: Physicochemical Characterization
by: Dajun Sun, et al.
Published: (2018-01-01)

Planning Bioequivalence Studies in the Context of the COVID-19 Pandemic
by: D. P. Romodanovsky, et al.
Published: (2021-03-01)

Generic - equivalent drugs use in internal and general medicine patients: distrust, confusion, lack of certainties or of knowledge? Part 2. Misconceptions, doubts and critical aspects when using generic drugs in the real world
by: Roberto Nardi, et al.
Published: (2014-05-01)

Changing paradigms in bioequivalence trials submitted to the EMA for evaluation – A clinical and regulatory perspective
by: Nathaniel Refalo, et al.
Published: (2017-02-01)

The use of GA‐RxODE (Genetics Algorithms and Running simulations from Ordinary Differential Equations‐based model) method to optimize bioequivalence studies
by: Ezequiel Omar Nuske, et al.
Published: (2021-10-01)

Generic - equivalent drugs use in internal and general medicine patients: distrust, confusion, lack of certainties or knowledge? Part 1. Pharmacological issues
by: Roberto Nardi, et al.
Published: (2014-05-01)

Bioequivalence and pharmacodynamics of a generic dabigatran etexilate capsule in healthy Chinese subjects under fasting and fed conditions
by: Xin Li, et al.
Published: (2020-04-01)

Shaping of the evidence-based substitution conceptual framework of the original medicines to generic counterparts in Ukraine
by: Viktoriia Dobrova, et al.
Published: (2021-08-01)

Regulatory requirements of the European Medicines Agency for evaluation of bioequivalence of modified-release medicinal products
by: D. P. Romodanovsky, et al.
Published: (2019-03-01)

Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: In Vitro Cellular Uptake
by: Min Wu, et al.
Published: (2017-12-01)

Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products of agomelatine in Chinese subjects
by: Fang Tang, et al.
Published: (2016-01-01)

Generic drugs and pharmacovigilance
by: Nelson Santiago Vispo
Published: (2017-11-01)

Bioequivalent pharmacokinetics for generic and originator hepatitis C direct-acting antivirals
by: Andrew Hill, et al.
Published: (2018-04-01)

Drug interchangeability: Clinical efficacy and safety
by: S. K. Zyryanov, et al.
Published: (2017-06-01)

BIOEQUIVALENCE STUDIES
by: Mihajlo B Jakovljević, et al.
Published: (2006-10-01)

Approval rating and opinion of outpatients and general practitioners toward generic drugs: a questionnaire-based real-world study
by: Mattioli F, et al.
Published: (2017-08-01)

First Symbicort Generic Gains Approval
by: Rubin, R.
Published: (2022)

Acceptability and barriers to implementation of N-of-1 tests in Ethiopia - a qualitative study
by: Chalachew Alemayehu, et al.
Published: (2019-10-01)

Cannot write session to /tmp/vufind_sessions/sess_67d4i6tracg0clcebnjbqov6j7